- Home
- NKTR vs CRF Comparison
NKTR vs CRF Comparison
Compare NKTR & CRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- CRF
- Stock Information
- Founded
- NKTR 1990
- CRF 1973
- Country
- NKTR United States
- CRF United States
- Employees
- NKTR N/A
- CRF N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- CRF Finance/Investors Services
- Sector
- NKTR Health Care
- CRF Finance
- Exchange
- NKTR Nasdaq
- CRF Nasdaq
- Market Cap
- NKTR 1.1B
- CRF 1.2B
- IPO Year
- NKTR 1994
- CRF N/A
- Fundamental
- Price
- NKTR $54.35
- CRF $7.72
- Analyst Decision
- NKTR Strong Buy
- CRF
- Analyst Count
- NKTR 5
- CRF 0
- Target Price
- NKTR $89.00
- CRF N/A
- AVG Volume (30 Days)
- NKTR 684.3K
- CRF 1.1M
- Earning Date
- NKTR 11-06-2025
- CRF 01-01-0001
- Dividend Yield
- NKTR N/A
- CRF 18.10%
- EPS Growth
- NKTR N/A
- CRF N/A
- EPS
- NKTR N/A
- CRF 1.40
- Revenue
- NKTR $62,600,000.00
- CRF $11,461,786.00
- Revenue This Year
- NKTR N/A
- CRF N/A
- Revenue Next Year
- NKTR N/A
- CRF N/A
- P/E Ratio
- NKTR N/A
- CRF $5.38
- Revenue Growth
- NKTR N/A
- CRF 6.53
- 52 Week Low
- NKTR $6.48
- CRF $5.70
- 52 Week High
- NKTR $66.92
- CRF $9.56
- Technical
- Relative Strength Index (RSI)
- NKTR 44.64
- CRF 32.91
- Support Level
- NKTR $52.50
- CRF $7.71
- Resistance Level
- NKTR $61.81
- CRF $7.92
- Average True Range (ATR)
- NKTR 3.62
- CRF 0.11
- MACD
- NKTR -0.51
- CRF -0.03
- Stochastic Oscillator
- NKTR 19.45
- CRF 25.56
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About CRF Cornerstone Total Return Fund Inc. (The)
Cornerstone Total Return Fund Inc is a diversified closed-end management company. Its objective is to seek capital appreciation with current income as a secondary objective. The company invests in sectors such as Information Technology; Health Care; Financials; Communication Services; Consumer Discretionary; Industrials; Exchange-Traded Funds; Utilities; Energy; Real Estate and others.